Endra Life Sciences Inc. (NDRA) Stock Price & Analysis

Endra Life Sciences Inc. (NDRA) rose 6.51% to USD 6.05 as of September 8, 2026 at 08:21 UTC, according to Nexqual real-time market data.

NDRA last closed at USD 6.05; the session ranged USD 5.7–6.37 on volume of 20,582 shares. Market capitalization is —, with a 52-week range of USD 2.96–9.85 (NCM). Source: Nexqual, September 8, 2026 at 08:21 UTC.

Key Statistics (as of September 8, 2026 at 08:21 UTC)

PriceUSD 6.05
Change▲ 6.51% (up)
Previous CloseUSD 6.05
OpenUSD 6.05
Day RangeUSD 5.7 – 6.37
52-Week RangeUSD 2.96 – 9.85
Volume20,582 shares
Market Cap
ExchangeNCM

Technical Analysis (NDRA)

Nexqual's technical model rates NDRA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 08:21 UTC.

Overall SignalSTRONG BUY
RSI (14)61.44 (neutral)
vs SMA50Above (USD 4.94)
MACD0.29 (positive)

From Endra Life Sciences Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
DAREDare Bioscience, Inc.USD 0.72▼ 2.57%
MOTSMotus GI Holdings, Inc.USD 0▲ 100%
MBIOMustang Bio, Inc.USD 0.54▼ 0.02%
MBAIMBody AI Ltd.USD 6.5▲ 0.31%
DCOYDecoy Therapeutics Inc.USD 2.69▼ 9.73%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:21 UTC. This page is informational and not investment advice.